Keynote Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Keynote Financial Services's PFE Position: Q2 2026 in Review
Keynote Financial Services reduced its Pfizer (PFE) stake by 0.95% in Q2 2026, selling an estimated $23.8K and leaving 94,489 shares worth $2.28M. The position accounts for 1.07% of the portfolio, ranked #22.
Keynote Financial Services first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.68M in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Keynote Financial Services held 94,489 shares of Pfizer worth $2.28M as of Q2 2026.
- Keynote Financial Services sold 910 Pfizer shares in Q2 2026, an estimated $23.8K.
- Pfizer made up 1.07% of Keynote Financial Services's portfolio in Q2 2026, its #22 holding.
- Keynote Financial Services first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
- Keynote Financial Services's Pfizer position peaked at $2.68M in Q1 2026.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.